Long-term follow-up for liver transplant recipients and living donors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective cohort will enroll adults who undergo liver transplantation or living donor hepatectomy at a single academic center in Hangzhou. Investigators will collect detailed clinical data and perform standardized long-term follow-up to document postoperative adverse events, functional outcomes, and quality of life for recipients and donors. The study aims to identify risk factors and to develop a specialized, individualized follow-up management system to optimize interventions. Participation requires informed consent and the ability to attend scheduled follow-up visits.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Patients undergoing liver transplantation or living donor hepatectomy at the study center (living donor should be approved by the hospital ethics committee for living organ donation);
2. Age 18 years or older;
3. Willing to participate in the long-term follow-up management program;
4. Signed informed consent form;

Exclusion Criteria:

1. Patients undergoing combined organ transplantation
2. Patients with severe mental illness or cognitive impairment who are unable to cooperate with follow-up assessments.
3. Donors whose surgery is aborted intraoperatively for any reason.
4. Unable or unwilling to comply with the long-term follow-up schedule.

Where it's running

• The Second Affiliated Hospital Zhejiang University School of Medicine
  Hangzhou, Zhejiang, China Recruiting

Study contacts

• Principal investigator: Wen Fang — Second Affiliated Hospital, Zhejiang University, School of Medicine
• Study coordinator: Wen Fang
• Email: wenfang@zju.edu.cn
• Phone: 19705094680

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• New approach to kidney transplantation using donor stem cells and regulatory T cells

  This study is testing a new treatment for people getting a kidney transplant that uses donor stem cells and special immune cells to see if it can help them avoid taking lifelong anti-rejection medication.

  Recruiting at 2 sites Phase 1 Stanford University · Palo Alto, California and 1 other locations · NCT03943238

• Pre-hepatectomy rehabilitation with mazdutide for obese MASLD donors

  This trial tests whether adding mazdutide to a structured lifestyle plan helps overweight MASLD donors lose liver fat faster to become eligible for donation.

  Recruiting Phase 4 West China Hospital · Hefei, Anhui and 3 other locations · NCT07718126

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.